Health & Fitness
Health and Fitness
Health and Fitness
Tue, March 22, 2011Mon, March 21, 2011Sun, March 20, 2011Fri, March 18, 2011Thu, March 17, 2011Wed, March 16, 2011Tue, March 15, 2011Mon, March 14, 2011Sun, March 13, 2011Sat, March 12, 2011Fri, March 11, 2011Thu, March 10, 2011Wed, March 9, 2011Tue, March 8, 2011Mon, March 7, 2011Sat, March 5, 2011Fri, March 4, 2011Thu, March 3, 2011Wed, March 2, 2011Synergetics USA, Inc. to Participate in the Roth Capitala?s Growth Stock Conference
Published in Health and Fitness on Thursday, March 10th 2011 at 13:20 GMT by Market Wire
Oa™FALLON, Mo.--([ BUSINESS WIRE ])--Synergetics USA, Inc. (NASDAQ: SURG) announced that the Company will participate in the Roth Capital Partners 23rd Annual OC Growth Stock Conference on Wednesday, March 16, 2011, at 2:00p.m.Pacific time. The Conference will beheld at The Ritz Carlton in Dana Point, California. Presenting on behalf of the Company at the Roth Conference will be David M. Hable, President and Chief Executive Officer; Pamela G. Boone, Executive Vice President and Chief Financial Officer; and Jason Stroisch, Vice President of International Sales and Marketing.
About Synergetics USA, Inc.
Through continuous improvement and development of our people, our mission is to design, manufacture and market innovative microsurgical devices, capital equipment, accessories and disposables of the highest quality in order to assist and enable surgeons who perform microsurgery around the world to provide a better quality of life for their patients.
Synergetics USA, Inc. (aSynergetics USAa or the aCompanya) is a leading supplier of precision microsurgical devices. The Companya™s primary focus is on the microsurgical disciplines of ophthalmology and neurosurgery. Our distribution channels include a combination of direct and independent sales organizations and important strategic alliances with market leaders. The Companya™s product lines focus upon precision engineered, microsurgical, hand-held instruments and the delivery of various energy modalities for the performance of less invasive microsurgery including: (i) laser energy, (ii) ultrasonic energy, (iii) radio frequency energy for electrosurgery and lesion generation and (iv) visible light energy for illumination, and where applicable, simultaneous infusion (irrigation) of fluids into the operative field. The Companya™s website address is [ http://www.synergeticsusa.com ].
Forward-Looking Statements
Some statements in this release may be aforward-looking statementsa for the purposes of the Private Securities Litigation Reform Act of 1995.In some cases forward-looking statements can be identified by words such as abelieve,a aexpect,a aanticipate,a aplan,a apotential,a acontinuea or similar expressions.Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements.These factors, risks and uncertainties are discussed in Synergeticsa™ Annual Report on Form 10-K for the yearended July31, 2010, as updated from time to time in our filings with the Securities and Exchange Commission.
